ketamine has been researched along with Movement Disorders in 7 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve opioid repsonse in patients with movement-related pain by using opioid switching adding a burst of ketamine." | 7.75 | Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. ( Arcuri, E; David, F; Ferrera, P; Mercadante, S; Villari, P, 2009) |
| "To improve opioid repsonse in patients with movement-related pain by using opioid switching adding a burst of ketamine." | 3.75 | Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. ( Arcuri, E; David, F; Ferrera, P; Mercadante, S; Villari, P, 2009) |
| "Ketamine produced dose-related increases in parkinsonian bradykinesia and dystonia as well as salivation." | 3.70 | Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates. ( Casey, DE; Shiigi, Y, 1999) |
| "The authors conclude that repeated intrathecal administration of preservative-free S(+)-ketamine in a clinically relevant concentration and dosage has, considering the extent and severity of the lesions, a toxic effect on the central nervous system of rabbits." | 1.33 | Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. ( de Haan, P; Dijkgraaf, MG; Hollmann, MW; Pennings, FA; Troost, D; van der Vegt, MH; Vranken, JH, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercadante, S | 1 |
| Villari, P | 1 |
| Ferrera, P | 1 |
| Arcuri, E | 1 |
| David, F | 1 |
| Min, SK | 1 |
| Lee, SY | 1 |
| Park, KS | 1 |
| Yoo, J | 1 |
| Chae, YJ | 1 |
| Deroza, PF | 1 |
| Ghedim, FV | 1 |
| Heylmann, AS | 1 |
| de Luca, RD | 1 |
| Budni, J | 1 |
| Souza, RP | 1 |
| Quevedo, J | 1 |
| Zugno, AI | 1 |
| Vranken, JH | 1 |
| Troost, D | 1 |
| de Haan, P | 1 |
| Pennings, FA | 1 |
| van der Vegt, MH | 1 |
| Dijkgraaf, MG | 1 |
| Hollmann, MW | 1 |
| Shiigi, Y | 1 |
| Casey, DE | 1 |
| Marco, LA | 1 |
| Joshi, RS | 1 |
| Cepeda, NJ | 1 |
| Rhyne, DB | 1 |
| Bennett, DR | 1 |
| Madsen, JA | 1 |
| Jordan, WS | 1 |
| Wiser, WC | 1 |
7 other studies available for ketamine and Movement Disorders
| Article | Year |
|---|---|
Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Bone Neoplasms; Humans; Ketamine; Male; Middle Aged; | 2009 |
Bolus effective dose of ketamine for preventing withdrawal movement on injection of rocuronium in paediatric patients.
Topics: Androstanols; Anesthetics, Intravenous; Child; Child, Preschool; Cross-Over Studies; Female; Humans; | 2011 |
Effect of cigarette smoke exposure in the behavioral changes induced by ketamine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Antag | 2012 |
Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine.
Topics: Anesthesia, Spinal; Anesthetics, Dissociative; Animals; Excitatory Amino Acid Antagonists; Female; I | 2006 |
Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates.
Topics: Animals; Behavior, Animal; Cebus; Dose-Response Relationship, Drug; Dystonia; Excitatory Amino Acid | 1999 |
Unitary correlates of linguo-pharyngeal events in a dyskinetic rat model.
Topics: Animals; Deglutition; Dyskinesia, Drug-Induced; Electric Stimulation; Hypoglossal Nerve; Ketamine; L | 1991 |
Ketamine anesthesia in brain-damaged epileptics. Electroencephalographic and clinical observations.
Topics: Adolescent; Adult; Anesthesia, Dental; Brain Damage, Chronic; Carbon Dioxide; Child; Child, Preschoo | 1973 |